• Twitter
  • LinkedIn
  • Instagram
  • Youtube
  • Facebook
  • Español Español Spanish es
  • Galego Galego Galician gl
  • English English English en
COVID-19: Información para empresas del ecosistema de salud gallego
Cluster Saúde de Galicia (CSG)
  • CSG
    • item oculto
      • Presentation
      • Mission, Vision and Objectives
      • CSG Organisation
      • Statutes and Regulations
      • Strategic plan
      • Strategic axes
      • Suggestions
  • FEDER
    • item-oculto
      • Galicia Exporta
      • neuroATLANTIC
      • TITTAN
  • News
    • item-oculto
      • News
      • Events
      • Blog
  • RIES Forum
  • Member area
    • item-oculto
      • Net #YOSOYDELCSG
      • CSG event registration
      • CSG Members data update form
  • Search
  • Menu Menu
  • CSG
    • Presentation
    • Mission, Visión and Objectives
    • CSG Organisation
    • Statutes and Internal Regulations
    • Strategic plan
    • Strategic axes
    • Suggestions
  • FEDER PROJECTS
  • News
    • News
    • Events
    • Blog
  • RIES Forum
  • Member Area
    • Network #YOSOYDELCSG
    • CSG events registration
  • Private Area
  • Twitter
  • Linkedin
  • Instagram
  • YouTube
  • Facebook
  • Spanish
  • Galician
  • English

The CSG seeks first level auditor for neuroATLANTIC.

26 de October de 2020/in CSG Press Room, Sector Press Room /by Cluster Saúde de Galicia (CSG)

The Cluster Saúde de Galicia, CSG, leads the neuroATLANTIC capitalization WP whose main objective is to transfer research into early detection methods for Alzheimer’s and stroke to the industry.

What is neuroATLANTIC?

Neurological diseases are disorders that affect the central nervous system and can impair the brain, spinal cord, peripheral nerve or neuromuscular function. Most of these diseases are directly related to ageing, with Alzheimer’s Disease (AD) and stroke being especially relevant due to their incidence and the economic burden they carry. More than 7.5 million European citizens aged between 30 and 99 years suffer from different types of dementia.

neuroATLANTIC project will contribute to address this challenge by proposing new standardized clinical protocols, innovative diagnostic and treatment methods and ensuring technology transfer to enterprises to favour the uptake of innovations in real settings. Specifically, neuroATLANTIC will act on the clinical, preclinical and capitalization aspects as following:

  1. The project will explore best clinical practices to elaborate a “green paper” to propose an improved clinical management (diagnosis and treatment) of Alzheimer´s Disease and stroke patients.
  2. neuroATLANTIC will set up a preclinical translational research platform with all the elements needed (animal models, nanostructures synthesis, assessment of exploitation potential, etc.) to bring innovative theragnostic agents and nanobiosensors (to be used to enhance diagnosis and treatment) to real settings. To test the translation platform feasibility, we will focus on two initial projects: biofunciontionalized nanostructures as contrast agents and nanobiosensors. These projects will give us useful insights to strengthen such platform in the future.
  3. neuroATLANTIC will pay attention to capitalization of results: technology roadmap and exploitation plans will be delivered for the selected projects; a governance structure will be defined in order to select new projects to be developed in the platform and, finally, R&D mission-oriented guidelines will be developed in order to define a strategic R&D agenda to address neurological diseases in the future.

You can send your proposals to gerencia@clustersaude.com

 

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail

Últimos artículos

  • The CSG seeks first level auditor for neuroATLANTIC.
  • CSG participated in the panel of speakers of the launching event of ECHAlliance Hesse Ecosystem
  • The CSG, ECOBAS and CINBIO begin their collaboration in Circular Economy projects at the Sinsal Litoral Festival
  • Final resolution of the connect-19 program: 4 selected companies from #EcosistemaCSG.
  • The CSG participates in a webinar on innovations in digital health organized by EPIC

Categorías

  • Blog
  • CSG Press Room
  • Foodtech
  • Healthcare
  • Healthtech
  • Sector Press Room
  • Support

THE CSG

  • Presentation
  • CSG Members
  • Strategic plan
  • CSG4Impact
  • FAQs

CSG ECOSYSTEM

  • Fórum RIES
  • Kit Saúde
  • LEX
  • Píldoras

FEDER

  • neuroATLANTIC
  • Galicia Exporta
  • TITTAN

COLLLABORATIONS

  • ECHAlliance
  • TIM MultiHelix
  • DIHDATALife

NEWS

  • Eventos
  • Blog

CONTACT

Avenida de Fernando de Casas Novoa 37
Edificio CNL.
Portal A-B. 1º andar
15707 Santiago de Compostela, A Coruña
T 602 24 71 49
info@clustersaude.com

© Cluster Saúde de Galicia (CSG)
  • Twitter
  • LinkedIn
  • Instagram
  • Youtube
  • Facebook
CSG participated in the panel of speakers of the launching event of ECHAlliance...
Scroll to top
Utilizamos cookies en nuestro sitio web para brindarle la experiencia más relevante al recordar sus preferencias y repetir visitas. Al hacer clic en "Aceptar", usted acepta el uso de TODAS las cookies. Sin embargo, puede visitar la Configuración de cookies para proporcionar un consentimiento controlado.
Configuración de cookiesAceptar
Política de cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Save & Accept